Qingzhou Kong

Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of <i>Helicobacter pylori</i> Infection (<scp>SHARE2301</scp>): A Multicenter, Noninferiority, Randomized Clinical Trial

Qingzhou Kong, Iqtida Ahmed Mirza, Xiaoqian Zhang et al. · Helicobacter · 2024 · 20 citations

Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Yuming Ding, Miao Duan, Zhongxue Han et al. · Digestive Diseases and Sciences · 2024 · 15 citations

Bismuth-containing Quadruple Therapy, Randomized Clinical Trial, Gastroenterology +1

Low compliance to <scp>post‐screening</scp> recommendations in a family‐based <i>Helicobacter pylori</i> screening and treatment program: A prospective cohort study

Qingzhou Kong, Yueyue Li, Ruili Li et al. · Helicobacter · 2022 · 13 citations

Comparative analysis of large language models in medical counseling: A focus on <i>Helicobacter pylori</i> infection

Qingzhou Kong, Kunping Ju, Meng Wan et al. · Helicobacter · 2024 · 12 citations

Health information in short videos about metabolic dysfunction‐associated steatotic liver disease: Analysing quality and reliability

Ruihao Ding, Qingzhou Kong, Longfei Sun et al. · Liver International · 2024 · 12 citations · Full text